U.S. House · 119th Congress · H.R. 5316

Drug Shortage Compounding Patient Access Act of 2025

To amend the Federal Food, Drug, and Cosmetic Act to ensure patients have access to certain shortage and urgent-use compounded medications, and for other purposes.

Follow

Log in to follow this bill and get an email when there’s a new vote (premium).

Sponsor
Diana HarshbargerR-TN-1
Introduced
September 11, 2025, in the House
Issue areas
Policy area
Health (from the Congressional Research Service)
Full text and actions
congress.gov

Votes on this bill (0)

Neither the House nor the Senate has held a roll-call vote on this bill.

Cosponsors (3)

3 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these

Original cosponsors

Signed on later